Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$197.69 - $227.29 $19,769 - $22,729
100 Added 0.62%
16,175 $3.68 Million
Q3 2023

Nov 09, 2023

BUY
$201.05 - $221.7 $87,657 - $96,661
436 Added 2.79%
16,075 $3.23 Million
Q2 2023

Aug 07, 2023

BUY
$211.93 - $241.33 $88,798 - $101,117
419 Added 2.75%
15,639 $3.24 Million
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $155,296 - $187,700
-728 Reduced 4.56%
15,220 $3.49 Million
Q4 2022

Feb 08, 2023

SELL
$203.72 - $248.97 $28,113 - $34,357
-138 Reduced 0.86%
15,948 $3.76 Million
Q3 2022

Nov 14, 2022

SELL
$204.81 - $262.19 $11.9 Million - $15.2 Million
-57,887 Reduced 78.25%
16,086 $3.3 Million
Q2 2022

Aug 10, 2022

SELL
$213.86 - $277.87 $35.9 Million - $46.6 Million
-167,735 Reduced 69.4%
73,973 $17.3 Million
Q1 2022

May 11, 2022

SELL
$259.82 - $298.18 $22.2 Million - $25.4 Million
-85,303 Reduced 26.09%
241,708 $63.7 Million
Q4 2021

Feb 10, 2022

BUY
$271.6 - $314.21 $15.6 Million - $18.1 Million
57,585 Added 21.37%
327,011 $102 Million
Q3 2021

Nov 10, 2021

BUY
$274.82 - $308.34 $48.8 Million - $54.8 Million
177,599 Added 193.41%
269,426 $75.8 Million
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $10.8 Million - $11.9 Million
42,962 Added 87.92%
91,827 $25.3 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $2.12 Million - $2.64 Million
10,339 Added 26.84%
48,865 $12.5 Million
Q4 2020

Feb 11, 2021

BUY
$186.91 - $214.42 $3.88 Million - $4.45 Million
20,775 Added 117.04%
38,526 $7.84 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $448,976 - $541,094
-2,688 Reduced 13.15%
17,751 $3.34 Million
Q2 2020

Aug 13, 2020

SELL
$113.31 - $182.44 $75,011 - $120,775
-662 Reduced 3.14%
20,439 $3.4 Million
Q1 2020

May 13, 2020

BUY
$104.32 - $195.28 $21,072 - $39,446
202 Added 0.97%
21,101 $2.67 Million
Q4 2019

Feb 14, 2020

BUY
$163.48 - $173.61 $521,174 - $553,468
3,188 Added 18.0%
20,899 $3.54 Million
Q3 2019

Nov 08, 2019

BUY
$159.77 - $178.1 $143,793 - $160,290
900 Added 5.35%
17,711 $2.98 Million
Q2 2019

Aug 09, 2019

BUY
$144.16 - $172.9 $183,083 - $219,583
1,270 Added 8.17%
16,811 $2.91 Million
Q1 2019

May 15, 2019

SELL
$123.7 - $156.3 $50,593 - $63,926
-409 Reduced 2.56%
15,541 $2.38 Million
Q4 2018

Feb 12, 2019

BUY
$120.82 - $174.09 $80,586 - $116,118
667 Added 4.36%
15,950 $2.02 Million
Q3 2018

Nov 05, 2018

SELL
$167.67 - $188.27 $18.2 Million - $20.4 Million
-108,594 Reduced 87.66%
15,283 $2.65 Million
Q2 2018

Aug 14, 2018

SELL
$160.33 - $189.41 $14.6 Million - $17.2 Million
-90,771 Reduced 42.29%
123,877 $22.2 Million
Q1 2018

Apr 30, 2018

SELL
$161.53 - $178.11 $1.94 Million - $2.14 Million
-12,019 Reduced 5.3%
214,648 $34.7 Million
Q4 2017

Feb 12, 2018

BUY
$147.99 - $163.95 $11.8 Million - $13 Million
79,512 Added 54.03%
226,667 $36.2 Million
Q3 2017

Nov 13, 2017

BUY
$149.47 - $160.56 $20 Million - $21.5 Million
133,900 Added 1010.18%
147,155 $22.2 Million
Q2 2017

Aug 14, 2017

BUY
N/A
13,255
13,255 $0

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Skandinaviska Enskilda Banken Ab (Publ) Portfolio

Follow Skandinaviska Enskilda Banken Ab (Publ) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.